The Asia Pacific Disposable Syringes Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).
Significant corporations are concentrating on making syringes intended solely to treat chronic diseases to strengthen their market position. Due to the ageing population's increased susceptibility to chronic illnesses, including diabetes and other lifestyle-related ailments, disposable syringes demand is predicted to rise in various healthcare settings. Old-aged people are more prone to develop cancer, diabetes, heart disease, cancer, COPS, neurological issues, and other chronic conditions. Such illnesses necessitate emergency and non-emergency hospital care, which is anticipated to accelerate market expansion soon.
Another primary driver of market expansion is government’s measures to promote using disposable medical supplies to avoid infections in operating rooms. Stroke, chronic obstructive pulmonary disease (COPD), ischemic heart disease, and type 2 diabetes are the most prevalent among people in China over the age of 60. Along with ongoing investments by the public and commercial sectors to encourage the use of safer and more affordable healthcare solutions, other factors driving market expansion include the ongoing construction of medical infrastructure.
According to WHO, China has one of the world's fastest-rising aging populations. Due to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040. The prevalence of diseases like diabetes, cancer, and others is anticipated to rise along with the aging population as they are predicted to be more susceptible to developing a variety of ailments. The market participants operating in the regional nations are expected to have significant growth opportunities due to all these factors.
The China market dominated the Asia Pacific Disposable Syringes Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,920.8 Million by 2030. The Japan market is poised to grow at a CAGR of 6.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.4% during (2023 - 2030).
Based on Application, the market is segmented into Therapeutic Injections, and Immunization Injections. Based on Product, the market is segmented into Safety Syringes (Retractable, and Non-retractable), and Conventional Syringes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Disposable Syringes Market is Projected to reach USD 22.5 Billion by 2030, at a CAGR of 6.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Fresenius SE & Co. KGaA, Terumo Corporation, Novo Nordisk A/S, Baxter International, Inc., B. Braun Melsungen AG, Flextronics International, Ltd., Nipro Corporation, and UltiMed, Inc.
By Application
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
